MALLORY AYCOCK: Open Payments
NPI 1982987376 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 42 payments from 14 companies in 2025. Trend: 2023 $120 · 2024 $1,017 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 9 | $258 |
| GENZYME CORPORATION | 8 | $246 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| Incyte Corporation | 1 | $132 |
| UCB, Inc. | 3 | $114 |
| ABBVIE INC. | 4 | $76 |
| LEO Pharma Inc. | 2 | $47 |
| PFIZER INC. | 2 | $35 |
| Organon LLC | 2 | $26 |
| Lilly USA, LLC | 1 | $23 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, ADBRY, CIBINQO, TALTZ, VTAMA.
Industry payments across GA — which companies pay providers there.
